Herpes Simplex - 31 Studies Found Withdrawn : A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease) : Herpes Simplex Virus : 2012-05-30 : Drug: Novel Antiviral Drug 4 o Completed : Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection : Herpes Simplex : 2000-02-24 : Drug: acyclovir Completed : Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth : Herpes Simplex : 2000-02-24 : Drug: acyclovir Completed : Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth : Herpes Simplex : 2002-03-06 : Drug: Acyclovir Oral suspensio Completed : Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates : Herpes Simplex : 2002-03-06 : Drug: Acyclovir Oral banana fl Completed : Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China : Influenza A Virus Infection Influenza B Virus Infection : 2011-10-21 : Drug: Zanamivir 10 mg inhaled Not yet recruiting : Liver Injury by Statins in Patients With History of Hepatitis B Virus Infection : Liver Injury Hepatitis B Virus Infection History : 2016-06-17 : Other: HBV infection history HBV infection history or HBV carriers Completed : Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-Positive Adults : Prophylaxis Herpes Simplex : 2008-06-13 : Biological: Herpes simplex candidate (gD) vaccine GSK208141 Intramuscular injection, 2 doses, 2 differen Completed : Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant : Prophylaxis Herpes Simplex : 2008-06-12 : Biological: Herpes simplex candidate vaccine GSK208141 - non-MPL-containing Completed : Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines : Prophylaxis Herpes Simplex : 2008-06-13 : Biological: Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141 Next >>>
